Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Phase II trial begins for Neurobiological Technologies' antiedema agent

Sep. 29, 1997

ICOS commences phase II trial for ischemic stroke; analyzes data for other indications

Sep. 29, 1997

Rhone-Poulenc Rorer discloses excitatory amino acid antagonists

Sep. 29, 1997

New morphinoid delta-opioid ligands from SmithKline Beecham

Sep. 29, 1997

Naramig safe and effective for acute treatment of migraine

Sep. 26, 1997

Guilford reports interim preclinical results with neurotrophic agent

Sep. 26, 1997

New indication for lamotrigine tested in patients: ADHD

Sep. 26, 1997

Metrifonate efficacy in AD demonstrated in clinical trial

Sep. 26, 1997

4030W92 preclinical activity and structure reported at Barcelona congress

Sep. 26, 1997

Entacapone clinical and preclinical data reported at neurology congress

Sep. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...